Legionella pneumophila is a facultative, intracellular gram-negative bacillus. Upon ingestion by cells of the monocyte-macrophage series, it resists destruction and, in fact, multiplies within these cells (6, 7, 26, 48) . Indirect activation of human monocytes in vitro by concanavalin A-stimulated lymphocyte supernatant has been shown to inhibit the intracellular multiplication of virulent L. pneumophila (27) . In this study, we evaluated the possibility of directly activating human monocyte-derived macrophages (MDMs) to restrict the intracellular multiplication of virulent L. pneumophila serogroup 1. The activation of the phagocytic cells was achieved with a bimolecular glycoprotein compound, RU 41.740, extracted from Klebsiella pneumoniae K201 (18) (19) (20) 46) . Activated macrophages are known to inhibit the growth of intracellular pathogens by both oxygenindependent and oxygen-dependent mechanisms, which involve the release of toxic oxygen radicals (5, 34, 42, 43) . MDMs activated by recombinant interferon gamma (8; J. L. Vilde, P. Rajagopalan, J. J. Pocidalo, and M. Brandely, Prog. Abstr. 26th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 1071, 1986) also inhibit the intracellular growth of L. pneumophila. In these reports and in an earlier report by Horwitz and Silverstein (27) , the cells were activated with products derived from T lymphocytes. In this study, the macrophages were activated nonspecifically and directly by a bacterial glycoprotein extract. Many bacterial products containing lipopolysaccharides have been shown to be potent activators of macrophages (3) . The K. pneumoniae extract RU 41 .740 has been shown to modulate the immune response (21, 39, 50, 51) and hence was used in this study to directly activate the cultured macrophages.
In the model used in this study, we demonstrate that (i) monocytes preincubated with a bacterial glycoprotein ex-* Corresponding author.
hibit metabolic oxidative burst in a chemiluminescence (CL) assay and (ii) direct nonspecific activation of MDMs by this glycoprotein slows the intracellular multiplication of virulent L. pneumophila.
(Part of this work was presented at the 6th International Congress of Immunology, Toronto, Canada, July 1986.)
MATERIALS AND METHODS
Bacteria. L. pneumophila serogroup 1 (strain Paris CB 81-13) was isolated from the lung of a patient who died from Legionnaires disease during a nosocomial outbreak in Paris, France. Crude lung homogenate was plated on buffered charcoal yeast extract agar supplemented with a-ketoglutarate (BCYE) and antibiotics. Plates were incubated at 35°C with 2.5% CO2 and 95% humidity. A single colony was taken after 72 h and plated onto BCYE plates, and bacteria were grown at 35°C to mid-logarithmic phase. The bacteria were harvested in sterile distilled water and tested for viability and the absence of contaminating bacteria. The concentration of the bacteria was then adjusted to 109 bacteria per ml, divided into samples, and stored at -70°C until use. The virulence of this strain, passaged twice in BCYE agar, was assessed by intraperitoneal infection of guinea pigs as described recently (14) . Infection of the macrophage monolayers. On day 7, the monolayer of MDMs was infected with L. pneumophila and 10% fresh immune serum in RPMI 1640 (bacteria-cell ratio, 10:1). At 1 h, in one well the supernatant containing the extracellular bacteria was removed and the intracellular L. pneumophila were enumerated after hypotonic lysis with sterile distilled water. In the rest of the wells, the supernatant was removed and the monolayers were rinsed vigorously with sterile phosphate-buffered saline (pH 7.2; 0.05 M) to remove any noninternalized bacteria and fed with fresh medium containing 10% normal serum, with (1.5 to 200 ,ug/ml) or without RU 41.740. The cultures were reincubated at 37°C with 5% CO2 for 24 h.
Erythromycin, which is the reference drug for the treatment of Legionnaires disease (16, 40) and which is known to inhibit the intracellular multiplication of virulent L. pneumophila within human monocytes (28, 49) Fig. 1 . Compared with the intracellular inoculum, 0.1 to 1.0 ,ug of erythromycin per ml, the positive control completely inhibited the intracellular multiplication of legionellae. Although there was inhibition of multiplication with 3.1 to 200 p.g of RU 41.740 per ml (P < 0.01 to , it was significantly less compared with erythromycin. The level of reduction in the intracellular multiplication of legionellae for concentrations ranging from 3.1 to 200 ,ug of RU 41.740 per ml did not show any dosedependent effect.
Comparison of the intracellular multiplication at 24 h with RU 41.740 to that without RU 41.740 is represented as a ratio in Fig. 2 . In the presence of concentrations of RU 41.740 ranging from 3.1 to 200 ,ug/ml, there was a significant reduction of the multiplication (log1o ratio below 0) compared with 1.5 p.g of RU 41.740 per ml (P < 0.03 to 0.001). The level of inhibition was not dose dependent. As observed with ratio 1, the reduction of the intracellular multiplication was significantly less (P < 0.01) compared with that of erythromycin.
Multiplication of L. pneumophila within MDMs preincubated for 72 h with RU 41.740. In the presence of macro- RU 41.740 (P < 0.05). The metabolic burst was dose dependent. Results are summarized in Table 3 . DISCUSSION L. pneumophila is a facultative intracellular bacterium multiplying within monocytes and macrophages of susceptible hosts (6, 7, 26, 48) . Upon ingestion, it multiplies within a specialized phagosome-lysosomal vacuole (22, 24) . Destruction of the bacteria is avoided by the inhibition of the fusion of the phagosome-lysosome (25) and nonacidification of the internal milieu of the vacuole (23) . Furthermore, the virulent bacteria, upon interaction with the phagocytic cells, inhibit the production of toxic oxygen-free radicals (J. L. Vildd, P. Rajagopalan, and E. Dournon, Prog. Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 65, 1983; P. Rajagopalan and E. Dournon, 4th Int. Symp. Bioluminescence Chemiluminescence, abstr. no. C 21, September 1986) to which it is otherwise susceptible (35, 36) . The bacteria are thus endowed with a host of antibacterial mechanisms which contribute to their intracellular survival.
Horwitz and Silverstein (27) (17) have provided the first evidence in vivo that activation of the nonspecific efferent arm (macrophage) of the immune response with mycobacteria can protect guinea pigs against a lethal L. pneumophila lung infection. It is fairly well known that macrophage activation by numerous microorganisms (37) and acidic polymers protects animals against infections and tumors (2). Activated mononuclear phagocytes (12, 38, 45) , particularly animal macrophages, have been reported to kill or inhibit the multiplication of Leishmania enrietti (9), Toxoplasma gondii (4), Trypanosoma cruzi (44) , Rickettsia tsutsugamushi (41) , and the bacterial pathogens Listeria monocytogenes (13, 15, 32) and Mycobacterium tuberculosis (10) .
The overall data of this study showed that in vitro the intracellular multiplication of L. pneumophila was significantly reduced in the presence of a bacterial glycoprotein (Fig. 2) but was not fully abolished as can be achieved with antibiotics (Fig. 1) . The reduction in the intracellular multiplication of legionellae was observed with activation done before or after infection. This effect was observed for concentrations as low as 6.2 ,ug/ml but was not significantly modified by increasing the concentrations up to 200 ,ug/ml.
The inhibition of the intracellular multiplication of L. pneumophila, in this model, was most probably due to the activation of macrophages for three reasons. (i) RU 41.740 alone, in the absence of macrophages, did not result in the reduction of the CFU of L. pneumophila (see above). (ii) RU 41.740 did not affect either the viability or the number of adhered macrophages. Since legionellae need macrophages for proliferation, reduction in the quantity of the cells would result in a limited rate of multiplication; this was verified by the normal yield and shape of the adhered macrophages, absence of the vital dye (trypan blue) uptake, and nonleakage of cytoplasmic LDH. (iii) In the absence of RU 41.740, the bacteria multiplied within cultured macrophages and did not trigger the metabolic burst, as observed in the CL assay.
That nonspecific activation of MDMs results in reduced multiplication of legionellae has been demonstrated by Horwitz and Silverstein (27 (5, 29, 30, 33, 34, 42, 43) . Since in acellular models these toxic oxygen radicals have been shown to be deleterious to L. pneumophila (35, 36) , one can speculate that RU 41.740-activated MDMs which produce free radicals, as evidenced by the CL assay, may inhibit the intracellular multiplication of virulent L. pneumophila.
